News
SAN FRANCISCO, CA, USA I August 06, 2025 I Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback